Coppell Advisory Solutions’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.95M | Buy |
6,686
+2,846
| +74% | +$1.26M | 0.35% | 54 |
|
|
2025
Q1 | $1.93M | Buy |
3,840
+3,356
| +693% | +$1.69M | 0.27% | 85 |
|
|
2024
Q4 | $193K | Buy |
484
+280
| +137% | +$112K | 0.03% | 281 |
|
|
2024
Q3 | $94.4K | Buy |
204
+112
| +122% | +$51.8K | 0.01% | 407 |
|
|
2024
Q2 | $43.1K | Buy |
+92
| New | +$43.1K | 0.01% | 537 |
|
|
2023
Q4 | $52.9K | Sell |
130
-31
| -19% | -$12.6K | 0.01% | 484 |
|
|
2023
Q3 | $46.5K | Buy |
161
+114
| +243% | +$32.9K | 0.02% | 326 |
|
|
2023
Q2 | $16.4K | Buy |
+47
| New | +$16.4K | ﹤0.01% | 601 |
|
|
2023
Q1 | – | Sell |
-161
| Closed | -$46.5K | – | 1067 |
|
|
2022
Q4 | $46.5K | Buy |
+161
| New | +$46.5K | 0.02% | 329 |
|